CRISPR Therapeutics AG
NASDAQ:CRSP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
CH |
|
Silvercorp Metals Inc
TSX:SVM
|
CA |
|
7digital Group plc
LSE:7DIG
|
UK |
|
Indrayani Biotech Ltd
BSE:526445
|
IN |
|
Ritchie Bros Auctioneers Inc
TSX:RBA
|
CA |
|
M
|
Mecaro Co Ltd
KOSDAQ:241770
|
KR |
|
Medinova Diagnostic Services Ltd
BSE:526301
|
IN |
|
Stantec Inc
TSX:STN
|
CA |
|
A
|
Adhi Kartiko Pratama Tbk PT
IDX:NICE
|
ID |
|
VIA Labs Inc
TWSE:6756
|
TW |
|
A
|
Axo Copper Corp
XTSX:AXO
|
CA |
Wall Street
Price Targets
CRSP Price Targets Summary
CRISPR Therapeutics AG
According to Wall Street analysts, the average 1-year price target for
CRSP
is 84.28 USD
with a low forecast of 33.33 USD and a high forecast of 330.75 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CRSP's stock price target?
Price Target
84.28
USD
According to Wall Street analysts, the average 1-year price target for
CRSP
is 84.28 USD
with a low forecast of 33.33 USD and a high forecast of 330.75 USD.
What is CRISPR Therapeutics AG's Revenue forecast?
Projected CAGR
463%
For the last 10 years the
compound annual growth rate for
CRISPR Therapeutics AG's revenue is
33%.
The projected
CAGR
for the next 3 years is
463%.
